GGrantIndex
← Leaderboards

Beth Israel Deaconess Medical Center

Boston, MA

Compare ↔
$3,136,623,114
Total funding
2,959
Grants

Funding over time

peak $197M · FY2005–25
$200M$150M$100M$50M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,094,304,460 · 2908
CDC$23,832,722 · 5
AHRQ$17,186,956 · 27
NSF$10,850,512 · 22

By mechanism

R01$1,683,089,078 · 863
P01$190,935,407 · 200
U19$164,113,482 · 38
UM1$136,295,343 · 8
U01$134,948,217 · 37
R21$105,464,415 · 253

Investigators at Beth Israel Deaconess Medical Center

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Ioannis Vlachos$3,412,1202 gr2Linus Tzu-Yen Tsai$3,279,6262 gr3Maria Mavrikaki$2,525,9411 gr4Laura G Burke$2,265,3372 gr5Yury Popov$1,267,5481 gr6Torsten Bjoern Meissner$1,206,2421 gr7Patric Liang$786,1881 gr8Arvind Panday$747,0001 gr

Emerging Leaders

6–10 yrs in

1Stephen P Juraschek$11,339,5985 gr2Mouhsin Shafi$6,715,5133 gr3Rishi Kumar Wadhera$5,884,0363 gr4Mark Andrew Sarzynski$4,936,8862 gr5Peter J Fried$4,283,7131 gr6Aaron F Struck$4,165,4962 gr7Emiliano Santarnecchi$3,497,1741 gr8Ari Moskowitz$3,296,4022 gr

All-Time

Most funded here, all years

1Christopher A Walsh$44,674,75711 gr2John V Frangioni$41,381,57717 gr3George C Tsokos$35,209,13916 gr4Elliot Chaikof$32,582,97415 gr5Joel K Elmquist$31,076,38211 gr6Martin R. Pollak$28,936,80915 gr7Dong-Er Zhang$28,922,20313 gr8Daniel G Tenen$28,339,81511 gr

Largest grants

Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine$18,931,665
U19 · FY2010 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine$16,612,311
U19 · FY2012 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine$13,210,979
U19 · FY2010 · AI
Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine$13,123,881
U19 · FY2009 · AI
Consortia for Innovative AIDS Research in Nonhuman Primates$11,020,286
UM1 · FY2017 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine$10,842,162
U19 · FY2009 · AI
Consortia for Innovative AIDS Research in Nonhuman Primates$9,472,469
UM1 · FY2018 · AI
Consortia for Innovative AIDS Research in Nonhuman Primates$8,756,867
UM1 · FY2019 · AI
Consortia for Innovative AIDS Research in Nonhuman Primates$8,268,211
UM1 · FY2020 · AI
Consortia for Innovative AIDS Research in Nonhuman Primates$8,268,168
UM1 · FY2021 · AI
Consortium for AIDS Vaccine Research in Nonhuman Primates$7,888,838
U19 · FY2014 · AI
Consortium for AIDS Vaccine Research in Nonhuman Primates$7,440,564
U19 · FY2015 · AI
Novel Adenovirus Vector-Based Vaccines for HIV-1$7,304,539
U19 · FY2006 · AI
Consortia for Innovative AIDS Research in Nonhuman Primates$7,245,181
UM1 · FY2016 · AI
Sensory Phenotyping to Enhance Neuropathic Pain Drug Development$7,081,684
UH3 · FY2025 · NS
Consortium for AIDS Vaccine Research in Nonhuman Primates$7,013,564
U19 · FY2011 · AI
Consortium for AIDS Vaccine Research in Nonhuman Primates$6,991,909
U19 · FY2012 · AI
The Moderate Alcohol and Cardiovascular Health Trial$6,831,998
U10 · FY2016 · AA
Consortium for AIDS Vaccine Research in Nonhuman Primates$6,572,396
U19 · FY2013 · AI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)$6,259,351
UM1 · FY2019 · AI